Richard Visconti

Statistics

Publications

Citations

324

H-Index

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Richard Visconti is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and molecular pharmacology.

ORCID

Publications per year

2009–2020

Publications

Bioprinted 3D Primary Human Intestinal Tissues Model Aspects of Native Physiology and ADME/Tox Functions

Lauran Madden, Theresa V. Nguyen, Salvador Garcia-Mojica et al. · iScience · 2018 · 153 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Characterizing Cannabinoid CB2 Receptor Ligands Using DiscoveRx PathHunter™ β-Arrestin Assay

Debra McGuinness, Asra Malikzay, Richard Visconti et al. · SLAS DISCOVERY · 2009 · 59 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

Human ileal organoid model recapitulates clinical incidence of diarrhea associated with small molecule drugs

David G. Belair, Richard Visconti, Miyoun Hong et al. · Toxicology in Vitro · 2020 · 51 citations · Full text

Medicine, Pharmacology, Cellular Pharmacology +13

A functional three-dimensional microphysiological human model of myeloma bone disease

Richard Visconti, Kyle L. Kolaja, Jessica Cottrell · Journal of Bone and Mineral Research · 2020 · 25 citations · Full text

Medicine, Bioengineering, Cell Biology +17

Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation

Shawn P. Walsh, Aurash Shahripour, Haifeng Tang et al. · ACS Medicinal Chemistry Letters · 2015 · 19 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

1–5 of 6